Skip to content
Clinical Trials for Alzheimer's Disease

Connecticut

Alzheimer's disease clinical trials in Connecticut

12 Alzheimer's disease studies are recruiting participants at sites in 4 cities across Connecticut as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Connecticut city with a recruiting study

New Haven (8), Farmington (2), Stamford (1), Westport (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Connecticut

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    New Haven
    Registry record
    NCT07177352 · updated
  2. Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Recruiting in
    Farmington
    Registry record
    NCT05980949 · updated
  3. A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

    • Phase 2
    • Ages 55 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Stamford
    Registry record
    NCT07589595 · updated
  4. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Recruiting in
    Farmington
    Registry record
    NCT06585787 · updated
  5. A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

    • Phase 2
    • Ages 50 to 85
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    New Haven
    Registry record
    NCT07033494 · updated
  6. Music for Pain and Dementia

    • No phase
    • Ages 50 to 80
    • All sexes
    Sponsor
    Yale University
    Recruiting in
    New Haven
    Registry record
    NCT07602283 · updated
  7. Exploring the Utility of [18F]3F4AP for Demyelination Imaging

    • Phase 1
    • Ages 18 to 90
    • All sexes
    Sponsor
    Yale University
    Recruiting in
    New Haven
    Registry record
    NCT06999434 · updated
  8. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Recruiting in
    New Haven
    Registry record
    NCT06563895 · updated
  9. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Recruiting in
    New Haven
    Registry record
    NCT05552157 · updated
  10. A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Recruiting in
    New Haven
    Registry record
    NCT06647498 · updated
  11. Neurologic Stem Cell Treatment Study

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    MD Stem Cells
    Recruiting in
    Westport
    Registry record
    NCT02795052 · updated
  12. Evaluation of a Mobile App Program for Coping With Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Yale University
    Recruiting in
    New Haven
    Registry record
    NCT06923501 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Connecticut on ClinicalTrials.gov.

Ask about studies in Connecticut

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call